A novel catecholamine, arbutamine, for a pharmacological cardiac stress agent

Cardiovascular Drugs and Therapy

Volumn 10, Issue 1, 1996, Pages 31-38

  Nagarajan, Ravi ^a   Abou Mohamed, Gamal ^a   Myers, Tammy ^a   Caldwell, Robert W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Arbutamine; Dobutamine; Dogs; Ischemia; Isoproterenol; Stress testing

Indexed keywords

ARBUTAMINE; CATECHOLAMINE DERIVATIVE; DOBUTAMINE; ISOPRENALINE; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; EXTRASYSTOLE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RATE; HEART STRESS; HEART STROKE VOLUME; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; ST SEGMENT; VASCULAR RESISTANCE;

EID: 0029997606     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051128     Document Type: Article

References (23)

1. Borer JS, Brensine JF, Redwood DR, et al. Limitations of the electrocardiographs response to exercise in predicting coronary artery disease. N Engl J Med 1975;293:367-371.
2. Marangelli V, Iliceto S, Piccinni G, De Martino G, Sorgiente L, Rizzon P. Detection of coronary artery disease by digital stress echocardiography: Comparison of exercise, transesophageal atrial pacing and dipyridamole echocardiography. J Am Coll Cardiol 1994;24:117-124.
3. Manca C, Bianchi G, Effendy FN, Blognesi R, Cucchini F, Visioli O. Comparison of five different stress testing methods in the ECG diagnosis of coronary artery disease. Cardiology 1979;64:325-332.
4. Nagarajan R, Parthasarathy S, Makilhan S, Bala Subramanian V. Isoproterenol - an alternative to exercise testing. Indian Heart J 1989;21:99-104.
5. Wexler H, Kuity J, Simonson E. Electrocardiographs effects of isoprenaline in normal subjects and patients with coronary atherosclerosis. Br Heart J 1971;33:759-764.
6. Combs DT, Martin CM. Evaluation of isoproterenol as a method of stress testing. Am Heart J 1974;6:711-715.
7. Lockett M. Dangerous effects of isoprenaline in myocardial failure. Lancet 1965;2:104-106.
8. Johnson GL, Ehrrich SJ, El-Hage AN, Balazs T. Effects of antiarrhythmic agents on isoproterenol induced ventricular fibrillation in heavy rats: A possible model of sudden cardiac death. Res Commun Chem Pathol Pharmacol 1986;51: 351-364.
9. Tuttle RR, Mills J. Development of a new catecholamine to selectively increase cardiac contractility. Circ Res 1975;36: 185-196.
10. Baptista J, Arnese M, Roelandt JR, et al. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: Correlations with dobutamine-atropine stress test. J Am Coll Cardiol 1994;23: 1434-1943.
11. Picano E, Diastante A, Masini M, Morales MA, Lattanzi F, L'Abbate A. Dipyridamole - Echocardiography test in effort angina pectoris. Am J Cardiol 1985;56:452-456.
12. Young M, Pan W, Wiesner J, et al. Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease. Drug Dev Res 1994;32:19-28.
13. Abou-Mohamed G, Nagarajan R, Ibrahim TM, Caldwell RW. Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing. Cardiovasc Drug Ther 1996;10:39-47.
14. Ruffolo RR, Spardlin TA, Pollock GD, Waddell JE, Murphy PF. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 1981;219:447-452.
15. Caldwell RW, Nash CB, Smulkowski M, Tuttle RR. Cardiovascular effects of KM-13, a new orally effective cardiotonic sympathomimetic amine. J Cardiovasc Pharmacol 1987;9: 375-384.
16. Ruffolo RR Jr. Review: The pharmacology of dobutamine. Am J Med Sci 1987;294:244-248.
17. Kenakin TP, Johnson SF. The importance of the alpha-adrenoceptor agonist activity of dobutamine to inotropic selectivity in anesthetized cat. Eur J Pharmacol 1985;111: 347-354.
18. Vatner SF, McRitchie RJ, Braunwald E. Effects of dobutamine on the left ventricular performance, coronary dynamics and distribution of cardiac output in conscious dogs. J Clin Invest 1974;53:1265-1273.
19. Bolter CP, Ledsome JR. Inotropic and chronotropic responses of the in vivo denervated dog myocardium to dobutamine. Can J Physiol Pharmacol 1976;54:618-621.
20. Sakanashi M, Tomamatsu E, Takeo S, et al. Effect of dobutamine on coronary circulation and cardiac metabolism of the dog. Drug Res 1978;28:798-801.
21. Abou-Mohamed G, Caldwell RW, Carrier GO, Elmazar MM, Tuttle RR. Interaction of a novel catecholamine, GP-128, with adrenergic receptors. J Cardiovasc Pharmacol 1994;23:492-500.
22. Kenakin TP. An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity. J Pharmacol Exp Ther 1981;216:210-219.
23. Ganong WF. Review of Medical Physiology, 16th ed. Norwalk, CT: Appleton and Lange, 1993, pp 574-575.